An impulse oscillometry system is less efficient than spirometry in tracking lung function improvements after intravenous antibiotic therapy in pediatric patients with cystic fibrosis

Pediatric Pulmonology
Clélia BuchsPhilippe Reix

Abstract

A literature search identified one retrospective study on the responsiveness of impulse oscillometry (IOS) in pediatric patients with cystic fibrosis. The aim of this prospective observational study was to assess this property in an adequately powered study after intravenous antibiotic therapy (IVAT) administered for an acute episode of pulmonary exacerbation. Spirometry and IOS were done on the same day as the start and the end of IVAT. Data from 34 patients' of mean age 11.9 years (range, 5-17 years) were studied. The mean FEV1 at the start and at the end of the IVAT was 73.1 ± 23.8% (range, 23.4-122%) and 88.3 ± 21.3% (range, 29.4-131%), respectively. The mean relative change (mean ± SD) was 20.2 ± 14.2% for FEV1 (ΔFEV1 ), -21.9 ± 23.8% for reactance at 5 Hz (ΔX5) and -13.4 ± 18.9% for resistance at 5 Hz (Δ R5) (all P-values <0.05). There was a weak but significant correlation between ΔFEV1 and ΔX5 (r =-0.473; p = 0.01). The magnitude of improvement of ΔX5 was not statistically different between patients with normal versus abnormal lung function at the start of IVAT. Furthermore, using ΔX5 alone as an outcome measure of IVAT efficiency resulted in a significant improvement in 44% of the patients, while it was 79% with ΔFEV1 ...Continue Reading

References

Sep 1, 1985·Pediatric Pulmonology·L SolymarR Sixt
Apr 1, 1973·Archives of Disease in Childhood·J J Cogswell
Sep 20, 2001·The Journal of Pediatrics·M RosenfeldB Ramsey
Dec 19, 2003·The European Respiratory Journal·E OostveenUNKNOWN ERS Task Force on Respiratory Impedance Measurements
Mar 19, 2004·American Journal of Respiratory and Critical Care Medicine·Kim G NielsenHans Bisgaard
Jul 2, 2005·Respiratory Physiology & Neurobiology·Michael D GoldmanDavid Ross
Aug 2, 2005·The European Respiratory Journal·M R MillerUNKNOWN ATS/ERS Task Force
Sep 17, 2005·American Journal of Respiratory and Critical Care Medicine·Nicola J StevensonPeter M A Calverley
Jun 27, 2006·Paediatric Respiratory Reviews·Kim G Nielsen
Jul 27, 2007·Proceedings of the American Thoracic Society·Margaret Rosenfeld
Aug 11, 2007·The European Respiratory Journal·C L GangellG L Hall
Jan 19, 2010·Pediatric Pulmonology·Harm A W M TiddensPeter D Paré
Mar 2, 2011·European Respiratory Review : an Official Journal of the European Respiratory Society·P-R Burgel
Jun 30, 2012·The European Respiratory Journal·Philip H QuanjerUNKNOWN ERS Global Lung Function Initiative
Oct 15, 2013·Pediatric Pulmonology·Clement L RenUNKNOWN Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis
Dec 10, 2013·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·L KentUNKNOWN European Cystic Fibrosis Society Clinical Trial Network (ECFS-CTN) Standardisation Committee

❮ Previous
Next ❯

Citations

May 14, 2016·Pediatric Pulmonology·Adrienne P Savant, Susanna A McColley
May 21, 2019·Physiotherapy Theory and Practice·Ana Carolina AlmeidaCamila Isabel Santos Schivinski
Aug 28, 2020·Pediatric Investigation·Julian Lewis AllenCharles C Clem
Sep 22, 2020·International Journal of Clinical Practice·Renata Maba Gonçalves WamosyCamila Isabel Santos Schivinski
Mar 19, 2021·Pediatric Allergy, Immunology, and Pulmonology·Gökçen Kartal ÖztürkEsen Demir
Apr 7, 2021·American Journal of Physiology. Lung Cellular and Molecular Physiology·Lennart K A Lundblad, Annette Robichaud
May 14, 2021·European Respiratory Review : an Official Journal of the European Respiratory Society·Charlie McLeodThomas L Snelling

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.